Laekna raises $61m to accelerate product development
The company launched six clinical programmes, with three multi-regional clinical trials for cancers.

The company launched six clinical programmes, with three multi-regional clinical trials for cancers.
For the fiscal year, the operating cash flow witnessed a 11.1% rise to $8.63bn (JPY1,123.1bn).
AnGes will make upfront and milestone payments up to $1.5m to Eiger, under the deal.
Jemincare will receive an upfront payment of $16m from Orion, as well as milestone and royalty payments.
In December last year, the DCGI approved the vaccine for emergency use in children of the age 12 to 18…
New projects will use the scientific research of the University of Tokyo with Astellas’ drug discovery expertise.
Under the deal, Porton will offer services to develop breakthrough cell therapies of Sinorda.
The takeover will offer Samsung Biologics with biosimilar development expertise and future performance in new drug development.
Thank you for subscribing to Pharmaceutical Technology